Orexia Therapeutics
Orexia is developing orexin receptor agonists for the treatment of narcolepsy, a rare neurological condition that affects the brain's ability to regulate the normal sleep-wake cycle Orexin, also called ‘hypocretin’, is a key regulator of wakefulness and REM sleep. We aspire to develop innovative medicines that address the full spectrum of orexin dysfunction in disease areas where there is high unmet clinical need. Orexia is designing novel oral small molecule OX2R agonists and positive modulators, which would influence orexin neurotransmission differently. Orexin agonists and positive modulators have the potential to treat a wide range of disorders which are inadequately treated today, most notably Narcolepsy Type 1 (NT1) which is caused by profound loss of orexin-producing neurons. NT1 is a chronic rare disease that usually starts during adolescence and is estimated to effect over 3 million people worldwide. Orexin agonists and positive modulators will directly address the underlying disease pathology of NT1, and may have the potential for greater efficacy and tolerability than current therapies. Orexia is founded by Medicxi in collaboration with Sosei Heptares and leverages their unique GPCR structure-based drug design (SBDD) capability for the discovery and development of promising drug candidates.
7-day free trial · no credit card
Verified contacts
4
available on Kipplo
LinkedIn employees
6
1 to 10 range
Open roles
—
no listings
Distinct roles
4
indexed titles
Tech stack
2
tools in use
Monthly traffic
420
organic / mo
Sign up free to see all 4 verified contacts at Orexia Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
4 contacts with verified email or phone · masked until revealed.
- FL
Frank Lovering
Computational Chemistry · Research & Development
EmailPhone - JM
Jonathan Mason
Senior Research Fellow, Computational Chemistry at Sosei Heptares & Orexia Therapeutics · Research & Development
EmailPhone - TR
Tino Rossi
Consultant Cmc and Preclinical Developability · Other
EmailPhone - ER
Emiliangelo Ratti
() · Other
EmailPhone
Showing 4 of 4 verified contacts
Top roles at Orexia Therapeutics
4 distinct titles indexed · top 4 shown.
- 1()
- 1computational chemistry
- 1consultant cmc and preclinical developability
- 1senior research fellow, computational chemistry at sosei heptares & orexia therapeutics
Sign up to unlock all 4 contacts at Orexia Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 4 verified contacts at Orexia Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.